-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TSWCJAMRfrkJ8+IsjPRd0cXvQa8+LE6xlW5QfGD4HUWtPM1tjnTND8myh4wyzmdu DosnTmDl3n0tDS6JI4NRyA== 0001072613-10-000366.txt : 20100312 0001072613-10-000366.hdr.sgml : 20100312 20100312161942 ACCESSION NUMBER: 0001072613-10-000366 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100310 FILED AS OF DATE: 20100312 DATE AS OF CHANGE: 20100312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Long Robert B CENTRAL INDEX KEY: 0001360415 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-05905 FILM NUMBER: 10678005 MAIL ADDRESS: STREET 1: 1715 WEST 38TH STREET CITY: CHATTANOOGA STATE: TN ZIP: 37343 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHATTEM INC CENTRAL INDEX KEY: 0000019520 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 620156300 STATE OF INCORPORATION: TN FISCAL YEAR END: 1130 BUSINESS ADDRESS: STREET 1: 1715 W 38TH ST CITY: CHATTANOOGA STATE: TN ZIP: 37409 BUSINESS PHONE: 4238214571 MAIL ADDRESS: STREET 1: 1715 W 38TH ST CITY: CHATTANOOGA STATE: TN ZIP: 37409 FORMER COMPANY: FORMER CONFORMED NAME: CHATTEM DRUG & CHEMICAL CO DATE OF NAME CHANGE: 19790111 4 1 long4-031010_16761ex.xml X0303 4 2010-03-10 0 0000019520 CHATTEM INC CHTT 0001360415 Long Robert B 1715 WEST 38TH STREET CHATTANOOGA TN 37343 0 1 0 0 Vice President and CFO 2005 Stock Option (right to buy) 36.5000 2010-03-10 4 D 0 6500 57.00 D 2012-04-24 Common Stock 6500 0 D 2005 Stock Option (right to buy) 59.7700 2010-03-10 4 D 0 12500 33.73 D 2013-04-25 Common Stock 12500 0 D 2005 Stock Option (right to buy) 70.9500 2010-03-10 4 D 0 12000 22.55 D 2014-04-30 Common Stock 12000 0 D 2009 Stock Option (right to buy) 55.5395 2010-03-10 4 D 0 15000 37.9605 D 2015-04-29 Common Stock 15000 0 D The options became fully vested and exercisable in accordance with their terms on February 9, 2010, upon the consummation of the tender offer commenced by River Acquisition Corp. ("River"), an indirect wholly-owned subsidiary of sanofi-aventis ("sanofi"), for all outstanding shares of issuer common stock. Pursuant to the Agreement and Plan of Merger, dated as of December 20, 2009, among the issuer, sanofi and River, the option was canceled in exchange for a cash payment equal to (i) the excess of (A) the merger consideration per share of issuer common stock (or $93.50 per share), over (B) the exercise price per share of issuer common stock subject to the option, multiplied by (ii) the number of shares of issuer common stock underlying the option. By: /s/ Robert B. Long 2010-03-12 -----END PRIVACY-ENHANCED MESSAGE-----